Drug intelligence / Profile preview

vinblastine

Development stage
Approved
Lead developer
Eli Lilly
Modality
Small Molecules
Administration
Intravenous
01

Overview

Vinblastine is a vinca alkaloid antineoplastic agent isolated from the periwinkle plant (Catharanthus roseus). It works by binding to tubulin, thereby inhibiting the assembly of microtubules and disrupting the mitotic spindle formation. This leads to M phase-specific cell cycle arrest and eventual cell death. At low concentrations, it suppresses microtubule dynamics, while at higher concentrations, it reduces microtubule polymer mass. Vinblastine is used to treat various cancers including Hodgkin's lymphoma, non-Hodgkin's lymphoma, breast cancer, testicular cancer, bladder cancer, and other conditions like histiocytosis and Kaposi's sarcoma.

Brand names
VelbanVelbeBlastivinCytoblastinLemblastineOncostinVelbastinVinblasinVinblastinVinkoWeibaodingXintoprost
Other names
VincaleukoblastineVincaleucoblastineVincaleucoblastinVincoblastineRozevinNincaluicolflastineVinblastinum
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on vinblastine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vinblastine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call